This website uses cookies. By continuing to browse our website, you are agreeing to our use of cookies. You can learn more about cookies by visiting our privacy & cookies policy page.

Over the counter
Top 3 Adult oral analgesics     
        £m change (m) change (%)
    Total volume change 3.7% Total category 383.1 15.6 4.2%
    Total own label 131.9 10.4 8.6%
1 1 Nurofen Reckitt Benckiser 79.9 -0.5 -0.6%
2 2 Solpadeine Omega Pharma 43.4 2.7 6.5%
3 3 Anadin Pfizer 22.5 -0.2 -0.8%
             
Top 3 Allergy remedies     
        £m change (m) change (%)
    Total volume change 9.2% Total category 128.4 11.6 9.9%
    Total own label      
1 1 Piriteze GSK 20.4 2.8 15.8%
2 2 Benadryl Johnson & Johnson 13.8 1.9 16.1%
3 3 Piriton GSK 11.3 1.0 9.3%
             
Top 3 Cold & flu remedies     
        £m change (m) change (%)
    Total volume change -1.0% Total category 514.8 20.1 4.1%
    Total own label      
1 1 Lemsip Reckitt Benckiser 66.0 3.2 5.0%
2 3 Strepsils Reckitt Benckiser 37.7 3.6 10.6%
3 5 Nurses GSK 35.8 4.5 14.3%
             
Top 3 Indigestion remedies     
        £m change (m) change (%)
    Total volume change -4.1% Total category 148.0 4.7 3.3%
    Total own label 17.9 -0.3 -1.7%
1 1 Gaviscon Reckitt Benckiser 65.3 1.0 1.5%
2 2 Rennie Bayer Consumer 30.3 0.1 0.3%
3 3 Nexium Pfizer 18.7 3.3 21.8%
             
Top 3 Paediatric analgesics     
        £m change (m) change (%)
    Total volume change 3.1% Total category 91.3 6.9 8.1%
    Total own label 11.1 1.5 15.6%
1 1 Calpol Johnson & Johnson 56.1 3.6 6.8%
2 2 Nurofen Reckitt Benckiser 18.6 1.4 8.3%
3 3 Calprofen Johnson & Johnson 2.5 -0.1 -5.5%
Nielsen, 52 w/e 8 September 2018